About 47,000 results
Open links in new tab
  1. Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine ...

    AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with …

  2. Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)

    Reduce involuntary movements with AUSTEDO XR® (deutetrabenazine) tablets treatment for TD. See safety info and boxed warning.

  3. Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide

    Aug 20, 2025 · Austedo's drug class is a VMAT2 inhibitor (vesicular monoamine transporter 2 inhibitor). Austedo tablets are taken twice daily, and the Austedo XR (extended-release) …

  4. Austedo: Regaining Control Over Uncontrolled Movements in ...

    Jul 16, 2024 · Austedo (aw-STED-oh) was approved in 2017 and is the first medicine approved to treat both tardive dyskinesia and chorea caused by Huntington’s disease.

  5. AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...

    Nov 7, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and …

  6. FDA Approves One Pill, Once-Daily Tablets of Deutetrabenazine ...

    May 30, 2024 · Key Takeaways Deutetrabenazine (Austedo XR) is now available as a once-daily, extended-release tablet for tardive dyskinesia and Huntington disease chorea, enhancing …

  7. Austedo XR Approved: A New Treatment Option for Tardive ...

    May 30, 2024 · The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.

  8. Teva Announces AUSTEDO® XR (deutetrabenazine) Extended ...

    May 29, 2024 · U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets (30, 36, 42, 48 mg/day) AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular …

  9. FDA approves new doses of Austedo XR for tardive dyskinesia ...

    Jun 3, 2024 · The FDA has approved Austedo XR in four new tablet strengths for adults diagnosed with tardive dyskinesia and chorea associated with Huntington’s disease, according …

  10. Tardive Dyskinesia (TD) Resources | AUSTEDO XR ...

    Resources for each step of the treatment journey with AUSTEDO XR Teva is committed to supporting your patients with tardive dyskinesia (TD) and their care partners.